<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01804114</url>
  </required_header>
  <id_info>
    <org_study_id>EH11-297</org_study_id>
    <nct_id>NCT01804114</nct_id>
  </id_info>
  <brief_title>Continuous Local Anesthetic Infusion Following Hernia Repair</brief_title>
  <official_title>Continuous Preperitoneal Infusion of Local Anesthetic Via Pain Pump for Laparoscopic Ventral Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NorthShore University HealthSystem</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kimberly-Clark Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>NorthShore University HealthSystem</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary endpoint of this study will determine if subjects receiving a continuous infusion&#xD;
      of local anesthetic following laparoscopic ventral hernia repair, with the pain pump&#xD;
      installed as described to treat post surgical pain will have a lower incidence of pain than&#xD;
      those patients treated with a placebo, saline-filled pain pump.The secondary endpoint of this&#xD;
      study will determine if subjects receiving a continuous infusion of local anesthetic&#xD;
      following laparoscopic ventral hernia repair, with the pain pump installed as described to&#xD;
      treat post surgical pain will have a lower utilization of narcotic analgesic medication than&#xD;
      those patients treated with the placebo, saline-filled pain pump.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be screened to determine study eligibility using inclusion/exclusion criteria.&#xD;
      Following the consent process, subjects will be randomly assigned to a treatment arm&#xD;
      (anesthetic or placebo group). Baseline data will be collected prior surgical implantation of&#xD;
      the pain pump delivery system. Both study and control groups will be able to receive&#xD;
      supplemental medication for breakthrough pain as determined by the surgeon. Post-operative&#xD;
      data will be collected up to three weeks following surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-Operative Pain</measure>
    <time_frame>Verbal Rating Scale used twice a day, up to 7 days postoperatively</time_frame>
    <description>Patients will self-report pain assessments on questionnaires each of the first seven days post-operatively using the 4 Point Verbal Rating Scale; ranging from 1=Severe Pain, to 4=No Pain, higher scores indicating less pain, or a better outcome. Values for two daily scores were averaged for each participant, the average across 7 days is reported.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Days With Post-Operative Narcotic Analgesic Use</measure>
    <time_frame>Up to 3 weeks post surgery</time_frame>
    <description>Patients given a diary to record all narcotics taken post-op for pain control.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Satisfaction With PostOperative Pain Management</measure>
    <time_frame>Satisfaction scores reported twice daily for up to the 7th day postoperatively</time_frame>
    <description>Subjects report satisfaction with how pain is managed for the first 7 days postoperatively, on a Numerical Rating Scale of 1-10; higher scores indicate less pain and greater satisfaction. Two daily scores were averaged to compute a single value for each day.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Ventral Hernia</condition>
  <arm_group>
    <arm_group_label>Local anesthetic continuous infusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pain management following hernia repair</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo continuous infusion</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo pain management following hernia repair</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pain management following hernia repair</intervention_name>
    <description>Continuous infusion of local anesthetic via pain pump following hernia repair</description>
    <arm_group_label>Local anesthetic continuous infusion</arm_group_label>
    <other_name>Placement of pain pump to manage post-operative hernia pain</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placebo for pain management following hernia repair</intervention_name>
    <description>Continuous infusion of placebo via pain pump following hernia repair</description>
    <arm_group_label>Placebo continuous infusion</arm_group_label>
    <other_name>Placement of placebo pain pump</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        &gt;18 years&#xD;
&#xD;
          -  ASA I,II,III&#xD;
&#xD;
          -  Scheduled for Laparoscopic Ventral Hernia Repair&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA IV or greater&#xD;
&#xD;
          -  Needing emergency surgery&#xD;
&#xD;
          -  Known history of drug abuse&#xD;
&#xD;
          -  GI, liver, kidney or other condition which, per the surgeon's opinion, could interfere&#xD;
             with the absorption, distribution, metabolism or excretion of any drug used during the&#xD;
             duration of the study&#xD;
&#xD;
          -  Patients with a prior allergic reaction or dependency to morphine, demerol, dilaudid,&#xD;
             fentanyl, marcaine(bupivicaine), lidocaine, or ropivicaine.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Ujiki, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NorthShore University HealthSystem</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NorthShore University HealthSystem</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>February 25, 2013</study_first_submitted>
  <study_first_submitted_qc>March 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2013</study_first_posted>
  <results_first_submitted>September 3, 2019</results_first_submitted>
  <results_first_submitted_qc>January 11, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">January 29, 2021</results_first_posted>
  <last_update_submitted>January 11, 2021</last_update_submitted>
  <last_update_submitted_qc>January 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>NorthShore University HealthSystem</investigator_affiliation>
    <investigator_full_name>Michael Ujiki MD</investigator_full_name>
    <investigator_title>Director of Minimally Invasive Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Two subjects were enrolled and withdrawn prior to assignment of arm/group because their surgeries were converted from laparoscopic to open.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Local Anesthetic Continuous Infusion</title>
          <description>Pain management following hernia repair&#xD;
Pain management following hernia repair: Continuous infusion of local anesthetic via pain pump following hernia repair</description>
        </group>
        <group group_id="P2">
          <title>Placebo Continuous Infusion</title>
          <description>Placebo pain management following hernia repair&#xD;
Placebo for pain management following hernia repair: Continuous infusion of placebo via pain pump following hernia repair</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Local Anesthetic Continuous Infusion</title>
          <description>Pain management following hernia repair&#xD;
Pain management following hernia repair: Continuous infusion of local anesthetic via pain pump following hernia repair</description>
        </group>
        <group group_id="B2">
          <title>Placebo Continuous Infusion</title>
          <description>Placebo pain management following hernia repair&#xD;
Placebo for pain management following hernia repair: Continuous infusion of placebo via pain pump following hernia repair</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="29"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.1" spread="12.2"/>
                    <measurement group_id="B2" value="60.9" spread="9.1"/>
                    <measurement group_id="B3" value="60.4" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Post-Operative Pain</title>
        <description>Patients will self-report pain assessments on questionnaires each of the first seven days post-operatively using the 4 Point Verbal Rating Scale; ranging from 1=Severe Pain, to 4=No Pain, higher scores indicating less pain, or a better outcome. Values for two daily scores were averaged for each participant, the average across 7 days is reported.</description>
        <time_frame>Verbal Rating Scale used twice a day, up to 7 days postoperatively</time_frame>
        <population>A verbal rating scale was used to collect self-reported outcomes; higher numbers indicated less pain.</population>
        <group_list>
          <group group_id="O1">
            <title>Local Anesthetic Continuous Infusion</title>
            <description>Pain management following hernia repair&#xD;
Pain management following hernia repair: Continuous infusion of local anesthetic via pain pump following hernia repair</description>
          </group>
          <group group_id="O2">
            <title>Placebo Continuous Infusion</title>
            <description>Placebo pain management following hernia repair&#xD;
Placebo for pain management following hernia repair: Continuous infusion of placebo via pain pump following hernia repair</description>
          </group>
        </group_list>
        <measure>
          <title>Post-Operative Pain</title>
          <description>Patients will self-report pain assessments on questionnaires each of the first seven days post-operatively using the 4 Point Verbal Rating Scale; ranging from 1=Severe Pain, to 4=No Pain, higher scores indicating less pain, or a better outcome. Values for two daily scores were averaged for each participant, the average across 7 days is reported.</description>
          <population>A verbal rating scale was used to collect self-reported outcomes; higher numbers indicated less pain.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.91" spread=".05"/>
                    <measurement group_id="O2" value="2.1" spread=".05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Days With Post-Operative Narcotic Analgesic Use</title>
        <description>Patients given a diary to record all narcotics taken post-op for pain control.</description>
        <time_frame>Up to 3 weeks post surgery</time_frame>
        <population>Subjects recorded days of postoperative narcotics used after discharge (this supplemented pump infusion). Of the total 29 receiving continuous infusion, 13 anesthetic infusion subjects completed the Post Operative Narcotic Analgesic Use Diary, and 8 placebo subjects completed this diary.</population>
        <group_list>
          <group group_id="O1">
            <title>Local Anesthetic Continuous Infusion</title>
            <description>Pain management following hernia repair&#xD;
Pain management following hernia repair: Continuous infusion of local anesthetic via pain pump following hernia repair</description>
          </group>
          <group group_id="O2">
            <title>Placebo Continuous Infusion</title>
            <description>Placebo pain management following hernia repair&#xD;
Placebo for pain management following hernia repair: Continuous infusion of placebo via pain pump following hernia repair</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Days With Post-Operative Narcotic Analgesic Use</title>
          <description>Patients given a diary to record all narcotics taken post-op for pain control.</description>
          <population>Subjects recorded days of postoperative narcotics used after discharge (this supplemented pump infusion). Of the total 29 receiving continuous infusion, 13 anesthetic infusion subjects completed the Post Operative Narcotic Analgesic Use Diary, and 8 placebo subjects completed this diary.</population>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O2" value="3" lower_limit="1" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Satisfaction With PostOperative Pain Management</title>
        <description>Subjects report satisfaction with how pain is managed for the first 7 days postoperatively, on a Numerical Rating Scale of 1-10; higher scores indicate less pain and greater satisfaction. Two daily scores were averaged to compute a single value for each day.</description>
        <time_frame>Satisfaction scores reported twice daily for up to the 7th day postoperatively</time_frame>
        <population>Subjects reported satisfaction of postoperative pain management on a range of 1-10; higher scores indicate less pain and greater satisfaction. The outcome is an average of 7 days of self-reported scores. Of the 17 subjects receiving continuous infusion of local anesthetic, 11 completed this questionnaire, and 6 of the 12 placebo subjects completed this questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Local Anesthetic Continuous Infusion</title>
            <description>Pain management following hernia repair&#xD;
Pain management following hernia repair: Continuous infusion of local anesthetic via pain pump following hernia repair</description>
          </group>
          <group group_id="O2">
            <title>Placebo Continuous Infusion</title>
            <description>Placebo pain management following hernia repair&#xD;
Placebo for pain management following hernia repair: Continuous infusion of placebo via pain pump following hernia repair</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction With PostOperative Pain Management</title>
          <description>Subjects report satisfaction with how pain is managed for the first 7 days postoperatively, on a Numerical Rating Scale of 1-10; higher scores indicate less pain and greater satisfaction. Two daily scores were averaged to compute a single value for each day.</description>
          <population>Subjects reported satisfaction of postoperative pain management on a range of 1-10; higher scores indicate less pain and greater satisfaction. The outcome is an average of 7 days of self-reported scores. Of the 17 subjects receiving continuous infusion of local anesthetic, 11 completed this questionnaire, and 6 of the 12 placebo subjects completed this questionnaire.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" spread=".4"/>
                    <measurement group_id="O2" value="9" spread=".5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Local Anesthetic Continuous Infusion</title>
          <description>Pain management following hernia repair&#xD;
Pain management following hernia repair: Continuous infusion of local anesthetic via pain pump following hernia repair</description>
        </group>
        <group group_id="E2">
          <title>Placebo Continuous Infusion</title>
          <description>Placebo pain management following hernia repair&#xD;
Placebo for pain management following hernia repair: Continuous infusion of placebo via pain pump following hernia repair</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michael Ujiki, MD</name_or_title>
      <organization>NSUHS</organization>
      <phone>8475701700</phone>
      <email>rpulido@northshore.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

